Related Articles
Chemoprevention of prostate cancer by diet-derived antioxidant agents and hormonal manipulation (Review)
Roles of autophagy‑related genes Beclin‑1 and LC3 in the development and progression of prostate cancer and benign prostatic hyperplasia
Inverse association of prostate cancer and non-steroidal anti-inflammatory drugs (NSAIDs): results of a case-control study.
Prostate cancer chemoprevention: models, limitations and potential (Review).
Potential repositioning of GV1001 as a therapeutic agent for testosterone‑induced benign prostatic hyperplasia